The pharmaceutical, biotech, and diagnostic companies are under constant pressure to accelerate drug discovery, maintain the quality & safety of drugs, and render effective therapies. While conducting clinical trials, these organizations need to undertake efforts to enhance the validity & safety of these trials, and take prudent decisions to stop unproductive programs & expedite the promising ones. Further, they also require following a streamlined process for marketing their new products. In order to address the challenges and opportunities occurring throughout the discovery to marketing cycle, it is imperative that these firms make use of core statistical analysis, data mining techniques, and predictive analytics.

Acer Innovation combines its rich industry experience and analytical capabilities to deliver quantifiable business value to the life sciences sector. By leveraging machine learning algorithms and topological data analysis techniques, we enable firms to identify potential risks, support clinical development, develop safer drugs, make medicine precise, speed up biomarker discovery, promote fast information sharing, and bring about operational effectiveness & efficiency.